Skip to main content
. 2020 Nov 27;6(48):eabc5022. doi: 10.1126/sciadv.abc5022

Fig. 3. BMP9 ablation accelerates insulin resistance and obesity.

Fig. 3

(A) GTT, (B) ITT, and (C) initial blood glucose comparison in CD-fed 16-week-old BMP9-KO mice (n = 6). (D) GTT, (E) ITT, and (F) initial blood glucose comparison in HFD-fed 16-week-old BMP9-KO mice (n = 6). (G) Weight gain of littermates fed a CD or HFD for 8 weeks (n = 6). (H) Representative photograph of CD-fed 16-week-old BMP9-KO mice (n = 3). Photo credit: P. Li, Photographer Institution, Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine. (I) Body weight (n = 6). (J) Comparison of fat mass and lean mass. *P < 0.05, **P < 0.01, and ***P < 0.001. ns, not significant.